Sandoz Group (OTCMKTS:SDZNY) Cut to “Hold” at UBS Group

UBS Group cut shares of Sandoz Group (OTCMKTS:SDZNY) from a strong-buy rating to a hold rating in a research report report published on Monday morning,Zacks.com reports.

Separately, BNP Paribas cut Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.

Sandoz Group Trading Up 4.1 %

Shares of SDZNY stock opened at $48.61 on Monday. The company’s fifty day moving average price is $43.52 and its two-hundred day moving average price is $43.20. Sandoz Group has a 12 month low of $27.79 and a 12 month high of $48.66.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.